A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China

Diabetes Therapy

Volumn 6, Issue 1, 2015, Pages 7-16

  Hu, Huimei ^a   Sawhney, Monika ^b   Shi, Lizheng ^c   Duan, Shengnan ^d   Yu, Yunxian ^a   Wu, Zhihong ^e   Qiu, Guixing ^e   Dong, Hengjin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MARSHALL UNIVERSITY   (United States)

^c TULANE UNIVERSITY   (United States)

^d DALIAN MEDICAL UNIVERSITY   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

China; Direct economic burden; Health care costs; Type 2 diabetes

Indexed keywords

CHINA; DIABETIC FOOT; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; ECONOMIC ASPECT; ECONOMIC BURDEN; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL CARE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INCOME; LENGTH OF STAY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RURAL AREA; SYSTEMATIC REVIEW; URBAN AREA;

EID: 84925753972     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-015-0096-0     Document Type: Review

References (43)

1. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.
2. International Diabetes Federation. Title of subordinate document. In: Diabetes Atlas 6th ed. 2014 Update. http://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf. Accessed 13 Nov 2011.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
4. Consultation WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland: World Health Organization. 1999;31(3):1–59.
5. Khaltaev NG. Prevention of diabetes mellitus. Prev Diabetes Mellitus. 1994;844:1–100.
6. National Diabetes Survey Group. Report on diabetes survey of 14 provinces and 300000 residents in China. Chin J Intern Med. 1981;20:678–83.
7. Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997;20(11):1664–9.
8. Xiang HD, Liu W, Liu CQ, et al. National baseline survey report on the epidemiology of diabetes in 1996. Chin J Diabetes. 1998;6:131–3.
9. Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;26(7):478–84.
10. Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.
11. Prevention and control assessment team of diabetes. Title of subordinate document. In: The blue book of Chinese diabetes prevention and control. 2011. http://www.cdschina.org/news_show.jsp?id=1099.html. Accessed 11 Nov 2011.
12. Gu K, Cowie CC, Harris MI. Mortality in adults with and within diabetes in a national cohort of the US population, 1971–1993. Diabetes Care. 1998;21(7):1138–45.
13. Mathers CD, Fat DM, Boerma JT. The global burden of disease: 2004 update. World Health Organization; 2008.
14. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;8(9):2130–5.
15. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002;45(7):S13–7.
16. Hu SL. The research of disease burden. Health Econ Res. 2005;5:22–7.
17. Shen HB, Yu SZ, Xu YC. A study on morbidity variance and economic burden of diabetes mellitus in China. Shanghai J Prev Med. 1998;10(9):387–90.
18. Tang L, Chen XB, Chen HY, Zhao LY, Hu SL. The economic burden of type 2 diabetes and its complications in the urban area of China. Chin Health Econ. 2003;22(12):21–3.
19. Hu JP, Rao KQ, Qian JC, Wu J. The study of economic burden of chronic non-communicable diseases in China. Chin J Prev Contr Chronic Non-Commu Dis. 2007;15(3):189–93.
20. Wang JS, Jin SG. Contribution of diabetes to the burden of disease. Chin J Prev Med. 2007;41(3):l86–8.
21. Liu KJ, Wang M. Economic burden of main chronic non-infectious diseases in China. Chin Health Econ. 2005;24:77–80.
22. Li LN. The study of disease burden of diabetes in China in 2008. Beijing: Beijing University of Chinese Medicine; 2011.
23. Zhao WH. The study on direct economic burden of diabetes in China [D]. Beijing: Peking Union Medical College; 2012.
24. Ministry of Health. National health services research: report of the second national health services survey in 1998. 1st ed. Beijing: People’s Health Publishing House; 1999.
25. Statistical Information Center. National health services research: report of the third national health services survey in 2004. 1st ed. Beijing: Peking Union Medical College Press; 2004.
26. Statistical Information Center. National health services research: report of the second national health services survey in 2008. 1st ed. Beijing: Peking Union Medical College Press; 2009.
27. Olsson J, Nilsson S, Persson U, et al. Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care. 1994;17(11):1257–63.
28. Currie CJ, Williams R, Peters JR. Patterns of inpatient and inpatient activity for diabetes; a district survey. Diabet Med. 1996;1:273–80.
29. Wang T, Yu BR, Yang F. An analysis on hospitalization costs and days of diabetes patients with different medical insurance types. Health Econ Resour. 2013;2:52–3.
30. Jiang JH, Zang TH, Yang MG, et al. Analysis on the factors influencing the length of hospital stay in the diabetic inpatients. Chin J Dis. 2001;5(4):313–5.
31. Chinese Diabetes Society. Chinese clinical guideline for type 2 diabetes (2012) [R]. Chin J Diabetes. 2013;22(8):2–42.
32. Zhang JL, Sun HM, Liu YQ, et al. A analysis on medical cost and its influencing factors in diabetes patients in Daqing. Theory Pract Chin Med. 2005;15(001):13–6.
33. Ministry of Health. Hospital classification management in China. 1st ed. Beijing: People’s Health Publishing House; 1989.
34. Sun HM, Chang BZ, Liu YQ, et al. Multivariate analysis on medical cost of diabetes patients. Health Econ Res. 2001;12:37–40.
35. Wang H. The relation between the medical cost of diabetes patients and general factors. Med Inform. 2011;24(8):4966–7.
36. Chen XB, Tang L, Chen HY, et al. Assessing the impact of complications on the costs of type 2 diabetes in urban China. Chin J Diabetes. 2003;11(4):238–41.
37. Wang JY, Xue YM, Ye XY. Analysis on key factors of the hospitalization cost of type 2 diabetes. Guangdong Med. 2007;28(9):1472–4.
38. He MZ, Li B, Bian Y. The structure analysis of hospitalization costs on diabetic in-patient. Chin Health Econ. 2009;28(11):22–4.
39. Guan XQ, Zheng YH, Wu QQ, et al. Investigation on current status of in-patient medical service and patient requirements. J First Mil Med Univ. 2002;22(5):472–5.
40. Xia SJ, Yang L, Hu SL. Analysis on the inpatient expenditure of diabetes mellitus and its complications. Chin Hosp Manag. 2004;24(9):40–2.
41. Li GY, Guo YP, Zheng RZ, et al. Screening for diabetes and the risk factors for type 2 diabetes in Daqing community citizens. Chin J Prev Control Chronic Non-Commun Dis. 2008;16(2):176–8.
42. Xing QL, Cao XG, Zhang Z, et al. The analysis on a correlation between the hospitalization cost and complications in diabetes patients. Chin J Prev Control Chronic Non-Commun Dis. 2003;11(6):283–4.
43. Lu W, Qiu YL, Ye L, et al. Analysis on the in- patient expenditure of Type 2 diabetes mellitus in Shanghai. Shanghai J Prev Med. 2007;19(2):80–2.